Lack of standardisation of ANA and implications for drug development and precision medicine
- PMID: 29574414
- DOI: 10.1136/annrheumdis-2018-213374
Lack of standardisation of ANA and implications for drug development and precision medicine
Keywords: disease activity; systemic lupus erythematosus; treatment.
Conflict of interest statement
Competing interests: MM is an employee of Inova Diagnostics.
Comment in
-
Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler.Ann Rheum Dis. 2019 May;78(5):e34. doi: 10.1136/annrheumdis-2018-213399. Epub 2018 Mar 28. Ann Rheum Dis. 2019. PMID: 29592916 No abstract available.
Comment on
-
Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE.Ann Rheum Dis. 2018 Jun;77(6):911-913. doi: 10.1136/annrheumdis-2017-212599. Epub 2018 Feb 9. Ann Rheum Dis. 2018. PMID: 29440000
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
